Published 1 month ago

GLP-1 agonist drugs like Ozempic do not increase thyroid cancer risk

Summary by Medical News Today

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

0 Articles

All

Left

Center

Right

Medical News Today

GLP-1 agonist drugs like Ozempic do not increase thyroid cancer risk

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

1 month ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.